Patents by Inventor Stephen H. Friend
Stephen H. Friend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10718025Abstract: The invention provides for methods for predicting age of a subject based on the epigenome of the subject.Type: GrantFiled: September 25, 2018Date of Patent: July 21, 2020Assignees: The Regents of the University of California, Sage BionetworksInventors: Kang Zhang, Gregory Hannum, Trey Ideker, Stephen H. Friend, Justin Guinney
-
Publication number: 20190032139Abstract: The invention provides for methods for predicting age of a subject based on the epigenome of the subject.Type: ApplicationFiled: September 25, 2018Publication date: January 31, 2019Inventors: Kang Zhang, Gregory Hannum, Trey Ideker, Stephen H. Friend, Justin Guinney
-
Patent number: 10087486Abstract: The invention provides for methods for predicting age of a subject based on the epigenome of the subject.Type: GrantFiled: November 12, 2013Date of Patent: October 2, 2018Assignees: The Regents of the University of California, Sage BionetworksInventors: Kang Zhang, Gregory Hannum, Trey Ideker, Stephen H Friend, Justin Guinney
-
Publication number: 20150259742Abstract: The invention provides for methods for predicting age of a subject based on the epigenome of the subject.Type: ApplicationFiled: November 12, 2013Publication date: September 17, 2015Inventors: Kang Zhang, Gregory Hannum, Trey Ideker, Stephen H. Friend, Justin Guinney
-
Patent number: 8753811Abstract: The present invention provides methods of making a population of nucleic acid molecules, wherein each nucleic acid molecule comprises a predetermined nucleic acid sequence, each of said methods comprising the steps of: (a) synthesizing, on a substrate, a population of nucleic acid molecules wherein: i) each synthesized nucleic acid molecule comprises a predetermined nucleic acid sequence; and ii) each synthesized nucleic acid molecule is localized to a defined area of said substrate; (b) harvesting said population of synthesized nucleic acid molecules from said substrate to yield harvested nucleic acid molecules; and (c) introducing said harvested nucleic acid molecules into vector molecules.Type: GrantFiled: February 16, 2012Date of Patent: June 17, 2014Assignee: Cold Spring Harbor LaboratoryInventors: Stephen H. Friend, Michele A. Cleary, Ernest M. Coffey, Kristopher A. Killian, Gregory J. Hannon, Patrick Paddison
-
Publication number: 20120149602Abstract: The present invention provides methods of making a population of nucleic acid molecules, wherein each nucleic acid molecule comprises a predetermined nucleic acid sequence, each of said methods comprising the steps of: (a) synthesizing, on a substrate, a population of nucleic acid molecules wherein: i) each synthesized nucleic acid molecule comprises a predetermined nucleic acid sequence; and ii) each synthesized nucleic acid molecule is localized to a defined area of said substrate; (b) harvesting said population of synthesized nucleic acid molecules from said substrate to yield harvested nucleic acid molecules; and (c) introducing said harvested nucleic acid molecules into vector molecules.Type: ApplicationFiled: February 16, 2012Publication date: June 14, 2012Inventors: Stephen H. FRIEND, Michele A. CLEARY, Kristopher A. KILIAN, Ernest M. COFFEY, Gregory J. HANNON, Patrick PADDISON
-
Patent number: 8133670Abstract: The present invention provides methods of making a population of nucleic acid molecules, wherein each nucleic acid molecule comprises a predetermined nucleic acid sequence, each of said methods comprising the steps of: (a) synthesizing, on a substrate, a population of nucleic acid molecules wherein: i) each synthesized nucleic acid molecule comprises a predetermined nucleic acid sequence; and ii) each synthesized nucleic acid molecule is localized to a defined area of said substrate; (b) harvesting said population of synthesized nucleic acid molecules from said substrate to yield harvested nucleic acid molecules; and (c) introducing said harvested nucleic acid molecules into vector molecules.Type: GrantFiled: June 2, 2004Date of Patent: March 13, 2012Assignees: Cold Spring Harbor Laboratory, Merck & Co., Inc.Inventors: Stephen H Friend, Michele A Cleary, Kristopher A Kilian, Ernest M Coffey, Gregory J Hannon, Patrick Paddison
-
Patent number: 8019552Abstract: The present invention provides prognostic methods for conditions such as cancer, for example, breast cancer, comprising classifying an individual by a plurality of phenotypic, genotypic or clinical characteristics of the condition into a plurality of patient subsets, and analyzing the pattern of expression of prognosis-informative genes identified for that subset in a sample from the individual. The present invention also provides methods for constructing such patient subsets and of identifying prognosis-informative genesets for such subsets. The invention further provides methods of assigning a therapeutic regimen to an individual, microarrays useful for performing prognosis, kits comprising these microarrays, and computer systems and programs for implementing the methods of the invention.Type: GrantFiled: March 7, 2005Date of Patent: September 13, 2011Assignees: The Netherlands Cancer Institute, Merck Sharp & Dohme Corp.Inventors: Hongyue Dai, Laura J. Van't Veer, John Lamb, Roland Stoughton, Stephen H. Friend, Yudong He
-
Patent number: 7807447Abstract: The present invention provides methods for analyzing exon expression profiles of a cell or type of cell. In the invention, the expression levels of a plurality of individual exons or multiexons for each of a plurality of genes in the genome of an organism are measured and analyzed to determine the biological state, such as the exon expression state or transcriptional state, of the cell or type of cell. The methods of the invention are useful for determination of alternative RNA splicing in a plurality of genes. The invention also provides nucleic acid probe arrays for determining in parallel the expression levels of a plurality of exons or multiexons for each of a plurality of genes in the genome of an organism. The invention further provides methods for determining the effects of perturbations, such as perturbations by drugs, on exon expression and alternative RNA splicing pathways.Type: GrantFiled: November 28, 2000Date of Patent: October 5, 2010Assignee: Merck Sharp & Dohme Corp.Inventors: Daniel D. Shoemaker, Stewart Scherer, Stephen H. Friend
-
Patent number: 7599799Abstract: The present invention provides methods for enhanced detection of biological response patterns. In one embodiment of the invention, genes are grouped into basis genesets according to the co-regulation of their expression. Expression of individual genes within a geneset is indicated with a single gene expression value for the geneset by a projection process. The expression values of genesets, rather than the expression of individual genes, are then used as the basis for comparison and detection of biological response with greatly enhanced sensitivity. In another embodiment of the invention, biological responses are grouped according to the similarity of their biological profile. The methods of the invention have many useful applications, particularly in the fields of drug development and discovery. For example, the methods of the invention may be used to compare biological responses with greatly enhanced sensitivity.Type: GrantFiled: October 18, 2002Date of Patent: October 6, 2009Assignee: Microsoft CorporationInventors: Stephen H. Friend, Roland Stoughton, Yudong He
-
Publication number: 20090204333Abstract: The present invention provides methods for enhanced detection of biological response patterns. In one embodiment of the invention, genes are grouped into basis genesets according to the co-regulation of their expression. Expression of individual genes within a geneset is indicated with a single gene expression value for the geneset by a projection process. The expression values of genesets, rather than the expression of individual genes, are then used as the basis for comparison and detection of biological response with greatly enhanced sensitivity. In another embodiment of the invention, biological responses are grouped according to the similarity of their biological profile. The methods of the invention have many useful applications, particularly in the fields of drug development and discovery. For example, the methods of the invention may be used to compare biological responses with greatly enhanced sensitivity.Type: ApplicationFiled: October 18, 2002Publication date: August 13, 2009Inventors: Stephen H. Friend, Roland Stoughton, Yudong He
-
Publication number: 20080187909Abstract: The present invention provides prognostic methods for conditions such as cancer, for example, breast cancer, comprising classifying an individual by a plurality of phenotypic, genotypic or clinical characteristics of the condition into a plurality of patient subsets, and analyzing the pattern of expression of prognosis-informative genes identified for that subset in a sample from the individual. The present invention also provides methods for constructing such patient subsets and of identifying prognosis-informative genesets for such subsets. The invention further provides methods of assigning a therapeutic regimen to an individual, microarrays useful for performing prognosis, kits comprising these microarrays, and computer systems and programs for implementing the methods of the invention.Type: ApplicationFiled: March 7, 2005Publication date: August 7, 2008Applicants: NETHERLANDS CANCER INSTITUTE, THE, ROSETTA INPHARMATICS LLCInventors: Hongyue Dai, Laura J. Van't Veer, John Lamb, Roland Stoughton, Stephen H. Friend, Yudong He
-
Patent number: 7173063Abstract: Methods for the treatment of a proliferative disorder are provided in which a subject in need of such treatment is administered an effective amount of a compound selected from: compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein X1 and X2 are independently H, Cl, F, Br, I, CN, CF3 or NO2, and Ar1 is a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl; and compounds of formula (II) wherein X3 and X4 are each independently H, Cl, F, Br, I, CN, CF3 or NO2; Y is (C2–C6)alkylene or (C2–C6)heteroalkylene; and Z is Cl, F, Br, I, CN, CF3 or NO2.Type: GrantFiled: November 10, 2000Date of Patent: February 6, 2007Assignee: Fred Hutchinson Cancer Research CenterInventors: John R. Lamb, Julian Simon, Heather Dunstan, Stephen H. Friend
-
Patent number: 7130746Abstract: The present invention provides methods for determining the level of protein activity in a cell by: (i) measuring abundances of cellular constituents in a cell in which the activity of a specific protein is to be determined so that a diagnostic profile is thus obtained; (ii) measuring abundances of cellular constituents that occur in a cell in response to perturbations in the activity of said protein to obtain response profiles and interpolating said response profiles to generate response curves; and (iii) determining a protein activity level at which the response profile extracted from the response curves best fits the measured diagnostic profile, according to some objective measure. In alternative embodiments, the present invention also provides methods for identifying individuals having genetic mutations or polymorphisms that disrupt protein activity, and methods for identifying drug activity in vivo by determining the activity levels of proteins which interact with said drugs.Type: GrantFiled: October 12, 2001Date of Patent: October 31, 2006Assignee: Rosetta Inpharmatics LLCInventors: Stephen H. Friend, Roland Stoughton
-
Patent number: 7122312Abstract: The present invention provides methods for identifying targets of a drug in a cell by comparing (i) the effects of the drug on a wild-type cell, (ii) the effects on a wild-type cell of modifications to a putative target of the drug, and (iii) the effects of the drug on a wild-type cell which has had the putative target modified of the drug. In various embodiments, the effects on the cell can be determined by measuring gene expression, protein abundances, protein activities, or a combination of such measurements. In various embodiments, modifications to a putative target in the cell can be made by modifications to the genes encoding the target, modification to abundances of RNAs encoding the target, modifications to abundances of target proteins, or modifications to activities of the target proteins. The present invention also provides methods for drug development based on the methods for identifying drug targets.Type: GrantFiled: August 30, 2002Date of Patent: October 17, 2006Assignee: Fred Hutchinson Cancer Research CenterInventors: Stephen H. Friend, Leland Hartwell
-
Patent number: 7013221Abstract: Methods and compositions are provided that are useful for detecting and reporting a plurality of different target polynucleotide sequences in a sample, such as polynucleotides corresponding to a plurality of different genes expressed by a cell or cells. In particular, the invention provides methods for screening a plurality of candidate polynucleotide probes to evaluate both the sensitivity and the specificity with which each candidate probe hybridizes to a target polynucleoide sequence. Candidate polynucleotide probes can then be ranked according to both their sensitivity and specificity, and probes that have optimal sensitivity and specificity for a target polynucleotide sequence can be selected. In one embodiment, polynucleotide probes can be selected according to the methods described herein to prepare “screening chips” wherein a large number of target polynucleotide sequences are detected using a single microarray have a few (e.g., 1–5) probes for each target polynucleotide sequence.Type: GrantFiled: April 28, 2000Date of Patent: March 14, 2006Assignee: Rosetta Inpharmatics LLCInventors: Stephen H. Friend, Roland Stoughton, Peter S. Linsley, Julja Burchard
-
Patent number: 6973388Abstract: The present invention provides methods for monitoring disease states in a subject, as well as methods for monitoring the levels of effect of therapies upon a subject having one or more disease states. The methods involve: (i) measuring abundances of cellular constituents in a cell from a subject to obtain a diagnostic profile, (ii) measuring abundances of cellular constituents in a cell of one or more analogous subjects to obtain perturbation response profiles which correlate to a particular disease or therapy, and (iii) determining the interpolated perturbation response profile or profiles which best fit the diagnostic profile. In other aspects, the invention also provides a computer system capable of performing the methods of the invention, databases comprising perturbation response profiles for one or more diseases and/or therapies, and kits for determining levels of disease states and/or therapeutic effects according to the methods of the invention.Type: GrantFiled: February 14, 2001Date of Patent: December 6, 2005Assignee: Rosetta Inpharmatics LLCInventors: Stephen H. Friend, Roland Stoughton
-
Patent number: 6950752Abstract: The invention provides methods for removing unwanted response components (i.e., “artifacts”) from a measured biological profile comprising measurements of a plurality of cellular constituents of a cell or organism in response to a perturbation. The methods involve subtracting from the measured biological profile one or more artifact patterns, each of which comprises measurements of changes in cellular constituents as a result of deviation of one or more experimental variables, such as cell culture density and temperature, hybridization temperature, as well as concentrations of total RNA and/or hybridization reagents, from desired values.Type: GrantFiled: December 23, 1998Date of Patent: September 27, 2005Assignee: Rosetta Inpharmatics LLCInventors: Stephen H. Friend, Roland Stoughton, Yudong He
-
Patent number: 6859735Abstract: The present invention provides methods and computer systems for identifying and representing the biological pathways of drug action on a cell The present invention also provides methods and computer systems for assessing the significance of the identified representation and for verifying that the identified pathways are actual pathway of drug action. The present invention also provides methods and computer systems for drug development based on the methods for identifying biological pathways of drug action, and methods and computer systems for representing the biological pathways involved in the effect of an environmental change upon a cell.Type: GrantFiled: August 13, 1999Date of Patent: February 22, 2005Assignee: Rosetta Inpharmatics LLCInventors: Roland Stoughton, Stephen H. Friend
-
Publication number: 20040259146Abstract: The present invention provides methods of making a population of nucleic acid molecules, wherein each nucleic acid molecule comprises a predetermined nucleic acid sequence, each of said methods comprising the steps of: (a) synthesizing, on a substrate, a population of nucleic acid molecules wherein: i) each synthesized nucleic acid molecule comprises a predetermined nucleic acid sequence; and ii) each synthesized nucleic acid molecule is localized to a defined area of said substrate; (b) harvesting said population of synthesized nucleic acid molecules from said substrate to yield harvested nucleic acid molecules; and (c) introducing said harvested nucleic acid molecules into vector molecules.Type: ApplicationFiled: June 2, 2004Publication date: December 23, 2004Applicants: Rosetta Inpharmatics LLC, Cold Spring Harbor LaboratoryInventors: Stephen H. Friend, Michele A. Cleary, Kristopher A. Kilian, Ernest M. Coffey, Gregory J. Hannon